XPH
SPDR S&P Pharmaceuticals ETF [XPH] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
XPH Stock Summary
Top XPH Correlated Resources
XPH
Top 10 Correlated ETFs
XPH
Top 10 Correlated Stocks
XPH
In the News
XPH Financial details
Company Rating
-
Market Cap
220.84M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.13
Dividend %
1.25%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-6.98%
SMA50
-6.98%
SMA100
8.11%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
34.67-45.62
52W High
-13.22%
52W Low
+14.85%
RSI
28
Rel Volume
0.32
Avg Volume
38.57K
Volume
12.5K
Perf Week
-5.65%
Perf Month
-9.21%
Perf Quarter
10.37%
Perf Half Y
1.96%
-
-
-
-
Beta
0.66
-
-
Volatility
0.4%, 1.3%
Prev Close
-0.13%
Price
39.05
Change
-1.16%
XPH Financial Performance
XPH Frequently Asked Questions
What is SPDR S&P Pharmaceuticals ETF stock symbol ?
SPDR S&P Pharmaceuticals ETF is a US stock and trading under the symbol XPH
What is SPDR S&P Pharmaceuticals ETF stock quote today ?
SPDR S&P Pharmaceuticals ETF stock price is $39.05 today.
Is SPDR S&P Pharmaceuticals ETF stock public?
Yes, SPDR S&P Pharmaceuticals ETF is a publicly traded company.
Company Profile
- Volume Average 38.57K
- Market Capitalization 220.84M
- Headquarters Boston,US
- IPO Date 2006-06-22
-
Website
https://www.ssga.com/us/en/intermediary/etfs/funds/spdr-sp-pharmaceuticals-etf-xph?fundSeoName=spdr-sp-pharmaceuticals-etf-XPH 
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
